1Cowie MR,Mendez GF. BNP and congestive heart failure[J].Prog cardio-vasc Dis,2002.293-321.
2KusterGM,TannerH,Printzen G,et a. l B-type natriuretic peptidefor diagnosis and treatment of congestive heart failure[J].SwissMedWkly,2003,(03):623-631.
4Maisel as,koon j,krishnaswamy p. Utility ofB- natriuretic peptide as a rapid,point- of- care test for screeningpatients undergoing echocard iography to determine leftventricular dysfunction[J].{H}American Heart Journal,2001,(03):367-374.
5Quyeu Dao;Padma Krishuasw amy;Radmila Kazanegra.查看详情[J],J Arn Col Cardilo2001379-385.
6Toru S,kazuhide Y,Osamu N. Screening for cardiac dyafunc-tion inasymptomatic patients by measuring B-type natriuretic peptide levels[J].Jpm Heart J,2000.205-214.
二级参考文献7
1Cowie MR,Mendez GF.BNP and congestive heart failure.Prog cardiovasc Dis,2002,44:293-321.
2Sudon T,Kangawa K,Minamino N,et al.A natriuretic peptide in porcine brain.Nature,1988,322:78.
4Tsutamoto T,Wada A,Maeda K,et al.Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure:Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction.Circulation,1997,96(2):509-516.
5Lee SC,Stevens TL,Sandberg SM,et al.The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure.J Card Fail,2002,8(3):149-154.
6TsutamoLo T,Wada A,Macda K,et al.Plasma brain natriuretic peptide levels as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction.Eur Heart J,1990,20:1799-1807.
2Muller HM,Rehak PH, Puchinger M, et al. Measurement of cardiac output and pulmonary Transit time for assess- ment of pulmonary vascular resistance in domestic piglets [J]. Exp Physiol,2009,94(6) :659-664.
